VERTEX PHARMACEUTICALS INC / MA (VRTX) Return on equity 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
21.2%FY2025 · since FY2016: -9.7% → 21.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.2% | +24.4 pp |
| FY2024 | -3.3% | -23.9 pp |
| FY2023 | 20.6% | -3.3 pp |
| FY2022 | 23.9% | +0.7 pp |
| FY2021 | 23.2% | -8.0 pp |
| FY2020 | 31.2% | +11.9 pp |
| FY2019 | 19.3% | -27.9 pp |
| FY2018 | 47.3% | +34.3 pp |
| FY2017 | 13.0% | +22.7 pp |
| FY2016 | -9.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice